Efficacy of direct-acting antiviral treatment for chronic hepatitis C: A single hospital experience

Table 5 Multivariable logistic regression models for SVR in patients with DCV/ASV

	Odds ratio	95%CI	P-value
Model 1: All variables
Platelet count	0.00	-0.01-0.27	0.71
AFP level	0.00	-0.00-0.01	0.44
ALT level	0.00	-0.00-0.01	0.31
HCV RNA level	0.26	0.02-0.45	0.04a
Age	0.02	-0.01-0.04	0.14
Sex	-0.13	-0.39-0.12	0.28
Y93	0.23	-0.31-0.77	0.38
L31	-0.17	-1.05-0.70	0.68
History of HCC	-0.29	-0.68-0.92	0.13
Cirrhosis	-0.30	-0.38-0.26	0.67
Prior IFN	-0.15	-0.41-0.99	0.21
Model 2: Limited suspicious covariates
Age	0.00	-0.13-0.14	0.93
Y93	0.48	0.08-0.87	0.02a
L31	-0.42	-1.09-0.24	0.2
Cirrhosis	-0.15	-0.37-0.08	0.19

Model 1: The baseline model considered with all covariates obtained. Model 2: Limited to covariates suspected from Table 4.

^aP < 0.05 were considered statistically significant. AFP: Alpha fetoprotein; ALT: Alanine aminotransferase; HCC: Hepatocellular carcinoma; IFN: Interferon.